Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionJane Street Group, Llc
Latest Disclosed Ownership6,207 shares
Latest Disclosed Value $ 817,710
Jane Street Group, Llc ownership in NBIX / Neurocrine Biosciences, Inc.

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 6,207 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $817,710 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 5,197 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 19.43% during the quarter.

Jane Street Group, Llc has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 80,600 of underlying shares valued at $10,618,244 USD and put options representing 181,600 of underlying shares valued at $23,923,984 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,207 1,010 19.43 818 10.85 0.0001
2026-02-12 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,197 -194,023 -97.39 737 -97.36 0.0001
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 199,220 192,138 2,713.05 27,967 3,042.25 0.0043
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,082 -4,660 -39.69 890 -31.43 0.0002
2025-05-19 2025-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 11,742 -88,028 -88.23 1,299 -90.47 0.0003
2025-05-14 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 33,942 -65,828 3,754 0.0008
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 99,770 75,254 306.96 13,619 382.22 0.0030
2024-11-15 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 24,516 -86,042 -77.83 2,825 -81.45 0.0006
2024-08-15 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 110,558 -141,446 -56.13 15,221 -56.21 0.0035
2024-05-16 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 252,004 238,124 1,715.59 34,756 1,801.31 0.0073
2024-02-15 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,880 -73,958 -84.20 1,829 -81.50 0.0005
2023-11-15 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 87,838 31,683 56.42 9,882 86.61 0.0032
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 56,155 -8,577 -13.25 5,295 -19.18 0.0018
2023-05-16 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 64,732 44,617 221.81 6,552 172.77 0.0027
2023-02-15 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 20,115 -110,298 -84.58 2,403 -82.66 0.0011
2022-11-15 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 130,413 82,597 172.74 13,851 197.17 0.0061
2022-08-16 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 47,816 -83,943 -63.71 4,661 -62.27 0.0020
2022-05-17 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 131,759 -49,408 -27.27 12,352 -19.95 0.0040
2022-02-15 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 181,167 49,957 38.07 15,430 22.61 0.0051
2021-11-16 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 131,210 104,441 390.16 12,585 383.11 0.0044
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 26,769 -31,478 -54.04 2,605 -54.02 0.0010
2021-05-18 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 58,247 -11,106 -16.01 5,665 -14.77 0.0028
2021-02-17 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 69,353 -3,786 -5.18 6,647 -5.49 0.0033
2020-11-17 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 73,139 21,446 41.49 7,033 11.51 0.0042
2020-08-17 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 51,693 42,979 493.22 6,307 735.36 0.0047
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,714 2,583 42.13 755 14.57 0.0007
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,131 111 1.84 659 21.59 0.0009
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,020 -56 -0.92 542 5.65 0.0009
2019-08-15 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,076 2,339 62.59 513 55.93 0.0009
2019-05-16 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,737 -2,244 -37.52 329 -22.95 0.0005
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,981 -17,552 -74.58 427 -85.24 0.0009
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,533 20,763 749.57 2,893 963.60 0.0057
2018-08-15 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,770 -16,963 -85.96 272 -83.37 0.0006
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,733 13,462 214.67 1,636 235.93 0.0042
2018-02-15 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,271 -10,228 -61.99 487 -51.83 0.0014
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,499 8,870 116.27 1,011 188.03 0.0033
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,629 2,737 55.95 351 41.53 0.0012
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,892 -20,802 -80.96 248 -78.77 0.0012
2016-08-15 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 25,694 9,127 55.09 1,168 78.32 0.0058
2016-05-17 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,567 11,351 217.62 655 122.03 0.0037
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,216 5,216 0.00 295 0.0018
2015-11-16 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -9,412 -100.00 0 -100.00
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,412 -3,707 -28.26 450 -13.63 0.0029
2015-05-12 2015-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 13,119 13,119 521 0.0040
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F NEUROCRINE BIOSCIENCES COM Call 80,600 -3.01 10,618 -9.91 n/a n/a n/a
2026-02-12 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Call 83,100 520.15 11,786 526.58 n/a n/a n/a
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM Call 13,400 -53.47 1,881 -48.02 n/a n/a n/a
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Call 28,800 -93.55 3,620 -92.68 n/a n/a n/a
2025-05-19 2025-03-31 13F/A NEUROCRINE BIOSCIENCES COM Call 446,800 502.97 49,416 388.59 n/a n/a n/a
2025-05-14 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Call 446,800 49,416 n/a n/a n/a
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Call 74,100 -44.99 10,115 -34.83 n/a n/a n/a
2024-11-15 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Call 134,700 87.60 15,520 57.02 n/a n/a n/a
2024-08-15 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Call 71,800 75.98 9,885 75.65 n/a n/a n/a
2024-05-16 2024-03-31 13F NEUROCRINE BIOSCIENCES COM Call 40,800 64.52 5,627 72.24 n/a n/a n/a
2024-02-15 2023-12-31 13F NEUROCRINE BIOSCIENCES COM Call 24,800 -66.26 3,268 -60.49 n/a n/a n/a
2023-11-15 2023-09-30 13F NEUROCRINE BIOSCIENCES COM Call 73,500 -42.71 8,269 -31.66 n/a n/a n/a
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM Call 128,300 1,409.41 12,099 1,306.74 n/a n/a n/a
2023-05-16 2023-03-31 13F NEUROCRINE BIOSCIENCES COM Call 8,500 -87.57 860 -89.47 n/a n/a n/a
2023-02-15 2022-12-31 13F NEUROCRINE BIOSCIENCES COM Call 68,400 -34.67 8,170 -26.54 n/a n/a n/a
2022-11-15 2022-09-30 13F NEUROCRINE BIOSCIENCES COM Call 104,700 -82.15 11,120 -80.56 n/a n/a n/a
2022-08-16 2022-06-30 13F NEUROCRINE BIOSCIENCES COM Call 586,700 432.40 57,192 453.60 n/a n/a n/a
2022-05-17 2022-03-31 13F NEUROCRINE BIOSCIENCES COM Call 110,200 -22.72 10,331 -14.94 n/a n/a n/a
2022-02-15 2021-12-31 13F NEUROCRINE BIOSCIENCES COM Call 142,600 79.15 12,145 59.09 n/a n/a n/a
2021-11-16 2021-09-30 13F NEUROCRINE BIOSCIENCES COM Call 79,600 1.53 7,634 0.05 n/a n/a n/a
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM Call 78,400 4.81 7,630 4.89 n/a n/a n/a
2021-05-18 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Call 74,800 98.41 7,274 101.27 n/a n/a n/a
2021-02-17 2020-12-31 13F NEUROCRINE BIOSCIENCES COM Call 37,700 -34.32 3,614 -34.53 n/a n/a n/a
2020-11-17 2020-09-30 13F NEUROCRINE BIOSCIENCES COM Call 57,400 32.56 5,520 4.49 n/a n/a n/a
2020-08-17 2020-06-30 13F NEUROCRINE BIOSCIENCES COM Call 43,300 79.67 5,283 153.26 n/a n/a n/a
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM Call 24,100 40.94 2,086 13.49 n/a n/a n/a
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM Call 17,100 451.61 1,838 558.78 n/a n/a n/a
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Call 3,100 -66.30 279 -64.09 n/a n/a n/a
2019-08-15 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Call 9,200 67.27 777 60.21 n/a n/a n/a
2019-05-16 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Call 5,500 485 n/a n/a n/a
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM Call 2,300 4.55 283 31.02 n/a n/a n/a
2018-08-15 2018-06-30 13F NEUROCRINE BIOSCIENCES COM Call 2,200 -64.52 216 -19.40 n/a n/a n/a
2017-05-15 2017-03-31 13F NEUROCRINE BIOSCIENCES COM Call 6,200 -82.92 268 -80.93 n/a n/a n/a
2017-02-15 2016-12-31 13F NEUROCRINE BIOSCIENCES COM Call 36,300 -13.98 1,405 -34.25 n/a n/a n/a
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM Call 42,200 0.72 2,137 12.24 n/a n/a n/a
2016-08-15 2016-06-30 13F NEUROCRINE BIOSCIENCES COM Call 41,900 1,904 n/a n/a n/a
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-11-16 2015-09-30 13F NEUROCRINE BIOSCIENCES COM Call 8,200 326 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F NEUROCRINE BIOSCIENCES COM Put 181,600 21.07 23,924 12.45 n/a n/a n/a
2026-02-12 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Put 150,000 148.76 21,274 151.35 n/a n/a n/a
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM Put 60,300 107.93 8,465 132.21 n/a n/a n/a
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Put 29,000 -44.55 3,645 -36.98 n/a n/a n/a
2025-05-19 2025-03-31 13F/A NEUROCRINE BIOSCIENCES COM Put 52,300 108.37 5,784 68.83 n/a n/a n/a
2025-05-14 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Put 52,300 5,784 n/a n/a n/a
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Put 25,100 -66.89 3,426 -60.77 n/a n/a n/a
2024-11-15 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Put 75,800 59.92 8,734 33.84 n/a n/a n/a
2024-08-15 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Put 47,400 -36.46 6,526 -36.58 n/a n/a n/a
2024-05-16 2024-03-31 13F NEUROCRINE BIOSCIENCES COM Put 74,600 132.40 10,289 143.27 n/a n/a n/a
2024-02-15 2023-12-31 13F NEUROCRINE BIOSCIENCES COM Put 32,100 -39.20 4,229 -28.80 n/a n/a n/a
2023-11-15 2023-09-30 13F NEUROCRINE BIOSCIENCES COM Put 52,800 45.05 5,940 73.08 n/a n/a n/a
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM Put 36,400 -26.46 3,433 -31.50 n/a n/a n/a
2023-05-16 2023-03-31 13F NEUROCRINE BIOSCIENCES COM Put 49,500 2,375.00 5,010 2,005.04 n/a n/a n/a
2023-02-15 2022-12-31 13F NEUROCRINE BIOSCIENCES COM Put 2,000 -98.94 239 -98.81 n/a n/a n/a
2022-11-15 2022-09-30 13F NEUROCRINE BIOSCIENCES COM Put 188,800 1.67 20,052 10.77 n/a n/a n/a
2022-08-16 2022-06-30 13F NEUROCRINE BIOSCIENCES COM Put 185,700 -37.09 18,102 -34.59 n/a n/a n/a
2022-05-17 2022-03-31 13F NEUROCRINE BIOSCIENCES COM Put 295,200 21.73 27,675 33.99 n/a n/a n/a
2022-02-15 2021-12-31 13F NEUROCRINE BIOSCIENCES COM Put 242,500 44.17 20,654 28.03 n/a n/a n/a
2021-11-16 2021-09-30 13F NEUROCRINE BIOSCIENCES COM Put 168,200 490.18 16,132 481.54 n/a n/a n/a
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM Put 28,500 -47.42 2,774 -47.37 n/a n/a n/a
2021-05-18 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Put 54,200 -8.75 5,271 -7.41 n/a n/a n/a
2021-02-17 2020-12-31 13F NEUROCRINE BIOSCIENCES COM Put 59,400 32.59 5,693 32.15 n/a n/a n/a
2020-11-17 2020-09-30 13F NEUROCRINE BIOSCIENCES COM Put 44,800 113.33 4,308 68.15 n/a n/a n/a
2020-08-17 2020-06-30 13F NEUROCRINE BIOSCIENCES COM Put 21,000 577.42 2,562 855.97 n/a n/a n/a
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM Put 3,100 -77.37 268 -81.81 n/a n/a n/a
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM Put 13,700 315.15 1,473 395.96 n/a n/a n/a
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Put 3,300 297 n/a n/a n/a
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-16 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Put 2,300 -28.12 203 -11.35 n/a n/a n/a
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM Put 3,200 -34.69 229 -61.96 n/a n/a n/a
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM Put 4,900 602 n/a n/a n/a
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-08-15 2016-06-30 13F NEUROCRINE BIOSCIENCES COM Put 32,100 1,459 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.